Related Experiment Video
Updated: Oct 27, 2025

09:21
A Ligated Intestinal Loop Model in Anesthetized Specific Pathogen Free Chickens to Study Clostridium Perfringens Virulence
Published on: October 11, 2018
9.7K
Centennial Review: Recent developments in host-pathogen interactions during necrotic enteritis in poultry
Nima K Emami1, Rami A Dalloul2
1Department of Poultry Science, University of Arkansas, Fayetteville, AR 72701, USA.
Poultry Science
|July 19, 2021
Summary
Necrotic enteritis (NE) in poultry causes significant economic losses. Understanding NE pathogenesis, microbiome, and immune responses is key to developing effective antibiotic alternatives for improved gut health and production.
Area of Science:
- Poultry Science
- Veterinary Medicine
- Microbiology
Background:
- Necrotic enteritis (NE) is a major poultry disease causing substantial global economic losses.
- Subclinical NE significantly impacts broiler performance (feed intake, weight gain, feed conversion ratio) with minimal mortality.
- Antibiotic growth promoters (AGPs) effectively managed NE, but their removal poses challenges to bird health and industry profitability.
Purpose of the Study:
- To review the complex relationship between NE pathogenesis, the gut microbiome, and host immune responses.
- To highlight the economic impact of NE, particularly subclinical forms, on the poultry industry.
- To explore the potential of antibiotic alternatives in managing NE and supporting gut health.
Main Methods:
- Literature review focusing on NE pathogenesis, microbiome dynamics, and host immunity.
- Analysis of existing research on antibiotic alternatives like probiotics, prebiotics, essential oils, and organic acids.
- Synthesis of information regarding the efficacy of these alternatives compared to AGPs.
Main Results:
- NE pathogenesis involves complex interactions between the host, pathogens, and gut microbiota.
- Subclinical NE has a greater economic impact than acute NE due to performance decrements.
- Current antibiotic alternatives show promise but have not fully matched AGP efficacy in controlling NE.
Conclusions:
- A deeper understanding of NE, microbiome, and immune interactions is crucial for strategic disease management.
- Developing novel supplements requires building upon current knowledge of NE pathogenesis and host responses.
- Effective strategies are needed to improve the efficacy of existing antibiotic alternatives or create next-generation gut health solutions.

